$Rocket Lab(RKLB.US) Context: RKLB just closed a $1.94B share sale to fund the Iridium buyout and the stock dropped about 5% on dilution worries. My take: management traded near term EPS dilution for balance sheet strength, they even killed a $3.6B bridge loan facility once the raise closed. If Iridium's recurring satcom revenue integrates cleanly by mid 2027 this dilution ages well. Watching how the stock behaves into year end before adding more.




